UK markets close in 3 hours 37 minutes

Bone Therapeutics SA (BNZPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.20000.0000 (0.00%)
At close: 11:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.2000
Open4.2000
BidN/A x N/A
AskN/A x N/A
Day's range4.2000 - 4.2000
52-week range4.2000 - 4.2600
Volume240
Avg. volume0
Market cap43.46M
Beta (5Y monthly)0.18
PE ratio (TTM)N/A
EPS (TTM)-0.8060
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Bone Therapeutics reports half year 2022 results

    REGULATED INFORMATION The interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can be accessed on the website of Bone Therapeutics in the section ‘Financial information’. Bone Therapeutics publishes its interim financial report in English. A French translation of the report will also be made available. In the event of differences between the English and the Frenc

  • Globe Newswire

    Bone Therapeutics to host Extraordinary General Meeting on 05 October 2022

    REGULATED INFORMATION As a result of a technical error in the publication dated August 26, 2022, the Board of Directors has decided to reconvene the extraordinary general meeting originally scheduled to be held on September 26, 202 and to postpone it to October 5, 2022 Preliminary documents for the Extraordinary General Meeting have been made available on company’s website Mont-Saint-Guibert, Belgium, 05 September 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell

  • Globe Newswire

    Bone Therapeutics SA: Information on the total number of voting rights and shares

    REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 31 August 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces an increase in the total number of voting rights and shares as a result of the issuance of new shares following the conversion of convertible bonds (CBs) issued on 9 June 2022. The following information is published in accordance with Article 15 of the Belgia